Anensen N - Search Results

1

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

Ersvaer E, Zhang JY, McCormack E, Olsnes A, Anensen N, Tan EM, Gjertsen BT, Bruserud O. Ersvaer E, et al. Among authors: anensen n. Eur J Haematol. 2007 Sep;79(3):210-25. doi: 10.1111/j.1600-0609.2007.00899.x. Epub 2007 Jul 26. Eur J Haematol. 2007. PMID: 17655707

2

Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy.

Sjøholt G, Anensen N, Wergeland L, Mc Cormack E, Bruserud Ø, Gjertsen BT. Sjøholt G, et al. Among authors: anensen n. Curr Drug Targets. 2005 Sep;6(6):631-46. doi: 10.2174/1389450054863671. Curr Drug Targets. 2005. PMID: 16178797 Review.

3

Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.

Bruserud Ø, Stapnes C, Tronstad KJ, Ryningen A, Anensen N, Gjertsen BT. Bruserud Ø, et al. Among authors: anensen n. Expert Opin Ther Targets. 2006 Feb;10(1):51-68. doi: 10.1517/14728222.10.1.51. Expert Opin Ther Targets. 2006. PMID: 16441228 Review.

4

Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.

Anensen N, Haaland I, D'Santos C, Van Belle W, Gjertsen BT. Anensen N, et al. Curr Pharm Biotechnol. 2006 Jun;7(3):199-207. doi: 10.2174/138920106777549731. Curr Pharm Biotechnol. 2006. PMID: 16789904 Review.

5

A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia.

Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT. Anensen N, et al. Clin Cancer Res. 2006 Jul 1;12(13):3985-92. doi: 10.1158/1078-0432.CCR-05-1970. Clin Cancer Res. 2006. PMID: 16818696

6

Early gene expression of acute myeloid leukemia in response to chemotherapy.

Anensen N, Øyan AM, Huseby S, Kalland KH, Bruserud Ø, Gjertsen BT. Anensen N, et al. Expert Rev Anticancer Ther. 2007 May;7(5):741-51. doi: 10.1586/14737140.7.5.741. Expert Rev Anticancer Ther. 2007. PMID: 17492937 Review.

7

Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

Øyan AM, Anensen N, Bø TH, Stordrange L, Jonassen I, Bruserud Ø, Kalland KH, Gjertsen BT. Øyan AM, et al. Among authors: anensen n. BMC Cancer. 2009 Mar 5;9:77. doi: 10.1186/1471-2407-9-77. BMC Cancer. 2009. PMID: 19265549 Free PMC article.

8

Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.

Ånensen N, Hjelle SM, Van Belle W, Haaland I, Silden E, Bourdon JC, Hovland R, Taskén K, Knappskog S, Lønning PE, Bruserud Ø, Gjertsen BT. Ånensen N, et al. Oncogene. 2012 Mar 22;31(12):1533-45. doi: 10.1038/onc.2011.348. Epub 2011 Aug 22. Oncogene. 2012. PMID: 21860418

9

Bcl-2 antisense in the treatment of human malignancies: a delusion in targeted therapy.

Gjertsen BT, Bredholt T, Anensen N, Vintermyr OK. Gjertsen BT, et al. Among authors: anensen n. Curr Pharm Biotechnol. 2007 Dec;8(6):373-81. doi: 10.2174/138920107783018381. Curr Pharm Biotechnol. 2007. PMID: 18289046 Review.

10

Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.

Irish JM, Anensen N, Hovland R, Skavland J, Børresen-Dale AL, Bruserud O, Nolan GP, Gjertsen BT. Irish JM, et al. Among authors: anensen n. Blood. 2007 Mar 15;109(6):2589-96. doi: 10.1182/blood-2006-02-004234. Epub 2006 Nov 14. Blood. 2007. PMID: 17105820 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters